Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
Sydney Airport flights disrupted due to air traffic controller shortage
Philippine firefighters enter charred ferry as search continues for dozens missing
Fire in rebel-held east Congo kills 24 schoolchildren
Trump says he does not regret Iran war despite potential impact on elections
Trump touts $5,000 payout if Republicans win as Vance waits in wings
Search expands after Philippine ferry fire kills five and leaves dozens missing
Trump says Iran war to end after US midterm elections
Cargo vessel fire at east China shipyard kills 25
